[MicroRNA-145-5p over-expression suppresses proliferation, migration and invasion and promotes apoptosis of human endometrial cancer cells by targeting dual specific phosphatase 6].


Journal

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
ISSN: 1673-4254
Titre abrégé: Nan Fang Yi Ke Da Xue Xue Bao
Pays: China
ID NLM: 101266132

Informations de publication

Date de publication:
30 Jan 2020
Historique:
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 1 7 2020
Statut: ppublish

Résumé

To investigate the role of microRNA-145-5p (miR-145-5p) in regulating the proliferation, migration, invasion and apoptosis of human endometrial carcinoma cells. Human endometrial carcinoma Ishikawa cells were transfected with miR-145-5p mimic, miR-145-5p inhibitor, or their negative controls via liposome (Lipo2000), and the changes in the expression of miR-145-5p was verified by real-time PCR. The effects of overexpression or inhibition of miR-145-5p on the proliferation, migration, invasion and apoptosis of the cells were evaluated using MTT assay, wound healing assay, Transwell assay or flow cytometry. Bioinformatic analysis was performed to predict the target genes of miR-145-5p. The mRNA and protein expression levels of the downstream target of miR-145-5p, namely dual specific phosphatase 6 (DUSP6), were detected using real-time PCR and Western blotting. Transfection of the cells with miR-145-5p mimic significantly suppressed the proliferation of Ishikawa cells, while transfection with miR-145-5p inhibitor obvious enhanced the proliferation of the cells ( Overexpression of miR-145-5p inhibits the proliferation, migration and invasion and promotes apoptosis of endometrial cancer cells possibly by negative regulation of DUSP6 expression.

Identifiants

pubmed: 32376567
doi: 10.12122/j.issn.1673-4254.2020.01.10
pmc: PMC7040756
doi:

Substances chimiques

MIRN145 microRNA, human 0
MicroRNAs 0
DUSP6 protein, human EC 3.1.3.48
Dual Specificity Phosphatase 6 EC 3.1.3.48

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

61-66

Références

J Cell Physiol. 2019 Aug;234(10):17824-17838
pubmed: 30993707
Gynecol Oncol. 2010 Oct;119(1):146-50
pubmed: 20638106
J Cell Biochem. 2019 Jun;120(6):10678-10687
pubmed: 30652343
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3485-3492
pubmed: 29917203
Bioengineered. 2019 Dec;10(1):1-12
pubmed: 30836864
Connect Tissue Res. 2017 Mar;58(2):155-161
pubmed: 27267924
Cancer Biol Med. 2018 Feb;15(1):14-28
pubmed: 29545965
J Cell Physiol. 2019 Mar;234(3):2581-2592
pubmed: 30229899
Exp Ther Med. 2019 Aug;18(2):1291-1298
pubmed: 31363373
Am J Cancer Res. 2017 Nov 01;7(11):2305-2317
pubmed: 29218252
World J Gastroenterol. 2017 Apr 7;23(13):2337-2345
pubmed: 28428713
Cell Physiol Biochem. 2016;39(5):1787-1794
pubmed: 27744452
Oncotarget. 2015 Sep 22;6(28):25226-39
pubmed: 26308072
Oncol Lett. 2019 Aug;18(2):1043-1048
pubmed: 31423164
Tumour Biol. 2016 Sep;37(9):11723-11732
pubmed: 27020591
Gene. 2013 Aug 10;525(2):162-9
pubmed: 23618815
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2777-2785
pubmed: 31002128
Bull Cancer. 2017 Dec;104(12):1022-1031
pubmed: 29110902
Carcinogenesis. 2008 Sep;29(9):1742-50
pubmed: 18632752
Oncol Lett. 2019 Sep;18(3):2684-2693
pubmed: 31404303
Am J Obstet Gynecol. 2017 Mar;216(3):268.e1-268.e18
pubmed: 27939327
Mol Oncol. 2019 Dec;13(12):2554-2573
pubmed: 31369196
Genes Cancer. 2017 May;8(5-6):566-576
pubmed: 28740575
J Cell Biochem. 2018 Feb;119(2):2022-2035
pubmed: 28833449
Oncotarget. 2017 Jun 22;8(37):61510-61527
pubmed: 28977881
Nat Rev Drug Discov. 2017 Mar;16(3):167-179
pubmed: 27444227
Cell Transplant. 2019 Sep-Oct;28(9-10):1299-1305
pubmed: 31271056
J Cell Physiol. 2020 Feb;235(2):1405-1416
pubmed: 31347176
J Cell Biochem. 2020 Feb;121(2):1504-1513
pubmed: 31498486
Mol Cell Endocrinol. 2013 Aug 25;376(1-2):60-9
pubmed: 23419500
Nat Rev Genet. 2016 Dec;17(12):719-732
pubmed: 27795564

Auteurs

Yingchao Men (Y)

Department of Biochemistry and Molecular Biology, Jinzhou Medical University, Jinzhou 121000, China.

Lei Zhang (L)

Department of Biochemistry and Molecular Biology, Jinzhou Medical University, Jinzhou 121000, China.

Hao Ai (H)

Department of Gynecology, Third Affiliated Hospital, Jinzhou Medical University, Jinzhou 121000, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH